Loading…

Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology?

1 Department of Membrane Biochemistry, Nijmegen Centre for Molecular Life Sciences, 2 Department of Paediatrics, Nijmegen Centre for Mitochondrial Disorders, and 3 Microscopical Imaging Centre of the Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, T...

Full description

Saved in:
Bibliographic Details
Published in:American Journal of Physiology: Cell Physiology 2007-07, Vol.293 (1), p.C22-C29
Main Authors: Koopman, Werner J. H, Verkaart, Sjoerd, Visch, Henk Jan, van Emst-de Vries, Sjenet, Nijtmans, Leo G. J, Smeitink, Jan A. M, Willems, Peter H. G. M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c480t-daabb55e2a2bcacbac7a9a452aceabf58fbd86d0bf66438602dca317255672dd3
cites cdi_FETCH-LOGICAL-c480t-daabb55e2a2bcacbac7a9a452aceabf58fbd86d0bf66438602dca317255672dd3
container_end_page C29
container_issue 1
container_start_page C22
container_title American Journal of Physiology: Cell Physiology
container_volume 293
creator Koopman, Werner J. H
Verkaart, Sjoerd
Visch, Henk Jan
van Emst-de Vries, Sjenet
Nijtmans, Leo G. J
Smeitink, Jan A. M
Willems, Peter H. G. M
description 1 Department of Membrane Biochemistry, Nijmegen Centre for Molecular Life Sciences, 2 Department of Paediatrics, Nijmegen Centre for Mitochondrial Disorders, and 3 Microscopical Imaging Centre of the Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands Submitted 20 April 2006 ; accepted in final form 10 April 2007 ABSTRACT Malfunction of NADH:ubiquinone oxidoreductase or complex I (CI), the first and largest complex of the mitochondrial oxidative phosphorylation system, has been implicated in a wide variety of human disorders. To demonstrate a quantitative relationship between CI amount and activity and mitochondrial shape and cellular reactive oxygen species (ROS) levels, we recently combined native electrophoresis and confocal and video microscopy of dermal fibroblasts of healthy control subjects and children with isolated CI deficiency. Individual mitochondria appeared fragmented and/or less branched in patient fibroblasts with a severely reduced CI amount and activity (class I), whereas patient cells in which these latter parameters were only moderately reduced displayed a normal mitochondrial morphology (class II). Moreover, cellular ROS levels were significantly more increased in class I compared with class II cells. We propose a mechanism in which a mutation-induced decrease in the cellular amount and activity of CI leads to enhanced ROS levels, which, in turn, induce mitochondrial fragmentation when not appropriately counterbalanced by the cell's antioxidant defense systems. complex I; reactive oxygen species; microscopy; fluorescence Address for reprint requests and other correspondence: P. H. G. M. Willems, 286 Membrane Biochemistry NCMLS, Radboud Univ. Nijmegen Medical Centre, P.O. Box 9101, NL-6500 HB Nijmegen, The Netherlands (e-mail: p.willems{at}ncmls.ru.nl )
doi_str_mv 10.1152/ajpcell.00194.2006
format article
fullrecord <record><control><sourceid>proquest_highw</sourceid><recordid>TN_cdi_proquest_miscellaneous_70717384</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1303846101</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-daabb55e2a2bcacbac7a9a452aceabf58fbd86d0bf66438602dca317255672dd3</originalsourceid><addsrcrecordid>eNp1kEtv1DAUhS0EokPhD7BAEQtWzeBXnEw3qJpSBqmCTVki6_qRiUeJndqx6Px7Mp0pSEis7uJ85-jqQ-gtwUtCKvoRdqO2fb_EmKz4kmIsnqHFHNCSVII9RwvMBCsF4ewMvUpphzHmVKxeojNSc9o0nCzQz00ewBffrq43l1m5--x88LYID86EaE3WEyRbGNs67azX-8signEa-kJ34Lc2Fc4Xg5uC7oI30c3BEOLYhT5s959eoxct9Mm-Od1z9OPm8916U95-__J1fXVbat7gqTQASlWVpUCVBq1A17ACXlHQFlRbNa0yjTBYtUJw1ghMjQZGalpVoqbGsHP04bg7xnCfbZrk4NLBDXgbcpI1rknNGj6D7_8BdyFHP_8mKcOMiZrQGaJHSMeQUrStHKMbIO4lwfJgXp7My0fz8mB-Lr07LWc1WPO3clI9A80R6Ny2--WilWO3T-5RlLzJfX9nH6anZbpiksg1pXI07Vy9-H_16Zc_FfYbT7SnRA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230336712</pqid></control><display><type>article</type><title>Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology?</title><source>American Physiological Society Free</source><creator>Koopman, Werner J. H ; Verkaart, Sjoerd ; Visch, Henk Jan ; van Emst-de Vries, Sjenet ; Nijtmans, Leo G. J ; Smeitink, Jan A. M ; Willems, Peter H. G. M</creator><creatorcontrib>Koopman, Werner J. H ; Verkaart, Sjoerd ; Visch, Henk Jan ; van Emst-de Vries, Sjenet ; Nijtmans, Leo G. J ; Smeitink, Jan A. M ; Willems, Peter H. G. M</creatorcontrib><description>1 Department of Membrane Biochemistry, Nijmegen Centre for Molecular Life Sciences, 2 Department of Paediatrics, Nijmegen Centre for Mitochondrial Disorders, and 3 Microscopical Imaging Centre of the Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands Submitted 20 April 2006 ; accepted in final form 10 April 2007 ABSTRACT Malfunction of NADH:ubiquinone oxidoreductase or complex I (CI), the first and largest complex of the mitochondrial oxidative phosphorylation system, has been implicated in a wide variety of human disorders. To demonstrate a quantitative relationship between CI amount and activity and mitochondrial shape and cellular reactive oxygen species (ROS) levels, we recently combined native electrophoresis and confocal and video microscopy of dermal fibroblasts of healthy control subjects and children with isolated CI deficiency. Individual mitochondria appeared fragmented and/or less branched in patient fibroblasts with a severely reduced CI amount and activity (class I), whereas patient cells in which these latter parameters were only moderately reduced displayed a normal mitochondrial morphology (class II). Moreover, cellular ROS levels were significantly more increased in class I compared with class II cells. We propose a mechanism in which a mutation-induced decrease in the cellular amount and activity of CI leads to enhanced ROS levels, which, in turn, induce mitochondrial fragmentation when not appropriately counterbalanced by the cell's antioxidant defense systems. complex I; reactive oxygen species; microscopy; fluorescence Address for reprint requests and other correspondence: P. H. G. M. Willems, 286 Membrane Biochemistry NCMLS, Radboud Univ. Nijmegen Medical Centre, P.O. Box 9101, NL-6500 HB Nijmegen, The Netherlands (e-mail: p.willems{at}ncmls.ru.nl )</description><identifier>ISSN: 0363-6143</identifier><identifier>EISSN: 1522-1563</identifier><identifier>DOI: 10.1152/ajpcell.00194.2006</identifier><identifier>PMID: 17428841</identifier><identifier>CODEN: AJPCDD</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Antioxidants ; Cell Line ; Cells ; Child ; Cluster Analysis ; Correlation analysis ; Electron Transport Complex I - antagonists &amp; inhibitors ; Electron Transport Complex I - deficiency ; Electron Transport Complex I - genetics ; Electron Transport Complex I - metabolism ; Electrophoresis ; Enzyme Inhibitors - pharmacology ; Enzymes ; Fibroblasts - drug effects ; Fibroblasts - enzymology ; Fibroblasts - metabolism ; Fibroblasts - pathology ; Genetic Predisposition to Disease ; Humans ; Membrane Potential, Mitochondrial ; Microscopy ; Microscopy, Confocal ; Microscopy, Video ; Mitochondria - drug effects ; Mitochondria - enzymology ; Mitochondria - metabolism ; Mitochondria - pathology ; Mitochondrial Diseases - enzymology ; Mitochondrial Diseases - genetics ; Mitochondrial Diseases - metabolism ; Mitochondrial Diseases - pathology ; Mitochondrial Proteins - metabolism ; Mitochondrial Size ; Mutation ; Oxidative Phosphorylation - drug effects ; Reactive Oxygen Species - metabolism ; Reproducibility of Results ; Rotenone - pharmacology ; Severity of Illness Index ; Uncoupling Agents - pharmacology</subject><ispartof>American Journal of Physiology: Cell Physiology, 2007-07, Vol.293 (1), p.C22-C29</ispartof><rights>Copyright American Physiological Society Jul 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-daabb55e2a2bcacbac7a9a452aceabf58fbd86d0bf66438602dca317255672dd3</citedby><cites>FETCH-LOGICAL-c480t-daabb55e2a2bcacbac7a9a452aceabf58fbd86d0bf66438602dca317255672dd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17428841$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koopman, Werner J. H</creatorcontrib><creatorcontrib>Verkaart, Sjoerd</creatorcontrib><creatorcontrib>Visch, Henk Jan</creatorcontrib><creatorcontrib>van Emst-de Vries, Sjenet</creatorcontrib><creatorcontrib>Nijtmans, Leo G. J</creatorcontrib><creatorcontrib>Smeitink, Jan A. M</creatorcontrib><creatorcontrib>Willems, Peter H. G. M</creatorcontrib><title>Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology?</title><title>American Journal of Physiology: Cell Physiology</title><addtitle>Am J Physiol Cell Physiol</addtitle><description>1 Department of Membrane Biochemistry, Nijmegen Centre for Molecular Life Sciences, 2 Department of Paediatrics, Nijmegen Centre for Mitochondrial Disorders, and 3 Microscopical Imaging Centre of the Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands Submitted 20 April 2006 ; accepted in final form 10 April 2007 ABSTRACT Malfunction of NADH:ubiquinone oxidoreductase or complex I (CI), the first and largest complex of the mitochondrial oxidative phosphorylation system, has been implicated in a wide variety of human disorders. To demonstrate a quantitative relationship between CI amount and activity and mitochondrial shape and cellular reactive oxygen species (ROS) levels, we recently combined native electrophoresis and confocal and video microscopy of dermal fibroblasts of healthy control subjects and children with isolated CI deficiency. Individual mitochondria appeared fragmented and/or less branched in patient fibroblasts with a severely reduced CI amount and activity (class I), whereas patient cells in which these latter parameters were only moderately reduced displayed a normal mitochondrial morphology (class II). Moreover, cellular ROS levels were significantly more increased in class I compared with class II cells. We propose a mechanism in which a mutation-induced decrease in the cellular amount and activity of CI leads to enhanced ROS levels, which, in turn, induce mitochondrial fragmentation when not appropriately counterbalanced by the cell's antioxidant defense systems. complex I; reactive oxygen species; microscopy; fluorescence Address for reprint requests and other correspondence: P. H. G. M. Willems, 286 Membrane Biochemistry NCMLS, Radboud Univ. Nijmegen Medical Centre, P.O. Box 9101, NL-6500 HB Nijmegen, The Netherlands (e-mail: p.willems{at}ncmls.ru.nl )</description><subject>Antioxidants</subject><subject>Cell Line</subject><subject>Cells</subject><subject>Child</subject><subject>Cluster Analysis</subject><subject>Correlation analysis</subject><subject>Electron Transport Complex I - antagonists &amp; inhibitors</subject><subject>Electron Transport Complex I - deficiency</subject><subject>Electron Transport Complex I - genetics</subject><subject>Electron Transport Complex I - metabolism</subject><subject>Electrophoresis</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Enzymes</subject><subject>Fibroblasts - drug effects</subject><subject>Fibroblasts - enzymology</subject><subject>Fibroblasts - metabolism</subject><subject>Fibroblasts - pathology</subject><subject>Genetic Predisposition to Disease</subject><subject>Humans</subject><subject>Membrane Potential, Mitochondrial</subject><subject>Microscopy</subject><subject>Microscopy, Confocal</subject><subject>Microscopy, Video</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - enzymology</subject><subject>Mitochondria - metabolism</subject><subject>Mitochondria - pathology</subject><subject>Mitochondrial Diseases - enzymology</subject><subject>Mitochondrial Diseases - genetics</subject><subject>Mitochondrial Diseases - metabolism</subject><subject>Mitochondrial Diseases - pathology</subject><subject>Mitochondrial Proteins - metabolism</subject><subject>Mitochondrial Size</subject><subject>Mutation</subject><subject>Oxidative Phosphorylation - drug effects</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Reproducibility of Results</subject><subject>Rotenone - pharmacology</subject><subject>Severity of Illness Index</subject><subject>Uncoupling Agents - pharmacology</subject><issn>0363-6143</issn><issn>1522-1563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNp1kEtv1DAUhS0EokPhD7BAEQtWzeBXnEw3qJpSBqmCTVki6_qRiUeJndqx6Px7Mp0pSEis7uJ85-jqQ-gtwUtCKvoRdqO2fb_EmKz4kmIsnqHFHNCSVII9RwvMBCsF4ewMvUpphzHmVKxeojNSc9o0nCzQz00ewBffrq43l1m5--x88LYID86EaE3WEyRbGNs67azX-8signEa-kJ34Lc2Fc4Xg5uC7oI30c3BEOLYhT5s959eoxct9Mm-Od1z9OPm8916U95-__J1fXVbat7gqTQASlWVpUCVBq1A17ACXlHQFlRbNa0yjTBYtUJw1ghMjQZGalpVoqbGsHP04bg7xnCfbZrk4NLBDXgbcpI1rknNGj6D7_8BdyFHP_8mKcOMiZrQGaJHSMeQUrStHKMbIO4lwfJgXp7My0fz8mB-Lr07LWc1WPO3clI9A80R6Ny2--WilWO3T-5RlLzJfX9nH6anZbpiksg1pXI07Vy9-H_16Zc_FfYbT7SnRA</recordid><startdate>20070701</startdate><enddate>20070701</enddate><creator>Koopman, Werner J. H</creator><creator>Verkaart, Sjoerd</creator><creator>Visch, Henk Jan</creator><creator>van Emst-de Vries, Sjenet</creator><creator>Nijtmans, Leo G. J</creator><creator>Smeitink, Jan A. M</creator><creator>Willems, Peter H. G. M</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TS</scope><scope>7X8</scope></search><sort><creationdate>20070701</creationdate><title>Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology?</title><author>Koopman, Werner J. H ; Verkaart, Sjoerd ; Visch, Henk Jan ; van Emst-de Vries, Sjenet ; Nijtmans, Leo G. J ; Smeitink, Jan A. M ; Willems, Peter H. G. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-daabb55e2a2bcacbac7a9a452aceabf58fbd86d0bf66438602dca317255672dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Antioxidants</topic><topic>Cell Line</topic><topic>Cells</topic><topic>Child</topic><topic>Cluster Analysis</topic><topic>Correlation analysis</topic><topic>Electron Transport Complex I - antagonists &amp; inhibitors</topic><topic>Electron Transport Complex I - deficiency</topic><topic>Electron Transport Complex I - genetics</topic><topic>Electron Transport Complex I - metabolism</topic><topic>Electrophoresis</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Enzymes</topic><topic>Fibroblasts - drug effects</topic><topic>Fibroblasts - enzymology</topic><topic>Fibroblasts - metabolism</topic><topic>Fibroblasts - pathology</topic><topic>Genetic Predisposition to Disease</topic><topic>Humans</topic><topic>Membrane Potential, Mitochondrial</topic><topic>Microscopy</topic><topic>Microscopy, Confocal</topic><topic>Microscopy, Video</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - enzymology</topic><topic>Mitochondria - metabolism</topic><topic>Mitochondria - pathology</topic><topic>Mitochondrial Diseases - enzymology</topic><topic>Mitochondrial Diseases - genetics</topic><topic>Mitochondrial Diseases - metabolism</topic><topic>Mitochondrial Diseases - pathology</topic><topic>Mitochondrial Proteins - metabolism</topic><topic>Mitochondrial Size</topic><topic>Mutation</topic><topic>Oxidative Phosphorylation - drug effects</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Reproducibility of Results</topic><topic>Rotenone - pharmacology</topic><topic>Severity of Illness Index</topic><topic>Uncoupling Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koopman, Werner J. H</creatorcontrib><creatorcontrib>Verkaart, Sjoerd</creatorcontrib><creatorcontrib>Visch, Henk Jan</creatorcontrib><creatorcontrib>van Emst-de Vries, Sjenet</creatorcontrib><creatorcontrib>Nijtmans, Leo G. J</creatorcontrib><creatorcontrib>Smeitink, Jan A. M</creatorcontrib><creatorcontrib>Willems, Peter H. G. M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Physical Education Index</collection><collection>MEDLINE - Academic</collection><jtitle>American Journal of Physiology: Cell Physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koopman, Werner J. H</au><au>Verkaart, Sjoerd</au><au>Visch, Henk Jan</au><au>van Emst-de Vries, Sjenet</au><au>Nijtmans, Leo G. J</au><au>Smeitink, Jan A. M</au><au>Willems, Peter H. G. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology?</atitle><jtitle>American Journal of Physiology: Cell Physiology</jtitle><addtitle>Am J Physiol Cell Physiol</addtitle><date>2007-07-01</date><risdate>2007</risdate><volume>293</volume><issue>1</issue><spage>C22</spage><epage>C29</epage><pages>C22-C29</pages><issn>0363-6143</issn><eissn>1522-1563</eissn><coden>AJPCDD</coden><abstract>1 Department of Membrane Biochemistry, Nijmegen Centre for Molecular Life Sciences, 2 Department of Paediatrics, Nijmegen Centre for Mitochondrial Disorders, and 3 Microscopical Imaging Centre of the Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands Submitted 20 April 2006 ; accepted in final form 10 April 2007 ABSTRACT Malfunction of NADH:ubiquinone oxidoreductase or complex I (CI), the first and largest complex of the mitochondrial oxidative phosphorylation system, has been implicated in a wide variety of human disorders. To demonstrate a quantitative relationship between CI amount and activity and mitochondrial shape and cellular reactive oxygen species (ROS) levels, we recently combined native electrophoresis and confocal and video microscopy of dermal fibroblasts of healthy control subjects and children with isolated CI deficiency. Individual mitochondria appeared fragmented and/or less branched in patient fibroblasts with a severely reduced CI amount and activity (class I), whereas patient cells in which these latter parameters were only moderately reduced displayed a normal mitochondrial morphology (class II). Moreover, cellular ROS levels were significantly more increased in class I compared with class II cells. We propose a mechanism in which a mutation-induced decrease in the cellular amount and activity of CI leads to enhanced ROS levels, which, in turn, induce mitochondrial fragmentation when not appropriately counterbalanced by the cell's antioxidant defense systems. complex I; reactive oxygen species; microscopy; fluorescence Address for reprint requests and other correspondence: P. H. G. M. Willems, 286 Membrane Biochemistry NCMLS, Radboud Univ. Nijmegen Medical Centre, P.O. Box 9101, NL-6500 HB Nijmegen, The Netherlands (e-mail: p.willems{at}ncmls.ru.nl )</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>17428841</pmid><doi>10.1152/ajpcell.00194.2006</doi></addata></record>
fulltext fulltext
identifier ISSN: 0363-6143
ispartof American Journal of Physiology: Cell Physiology, 2007-07, Vol.293 (1), p.C22-C29
issn 0363-6143
1522-1563
language eng
recordid cdi_proquest_miscellaneous_70717384
source American Physiological Society Free
subjects Antioxidants
Cell Line
Cells
Child
Cluster Analysis
Correlation analysis
Electron Transport Complex I - antagonists & inhibitors
Electron Transport Complex I - deficiency
Electron Transport Complex I - genetics
Electron Transport Complex I - metabolism
Electrophoresis
Enzyme Inhibitors - pharmacology
Enzymes
Fibroblasts - drug effects
Fibroblasts - enzymology
Fibroblasts - metabolism
Fibroblasts - pathology
Genetic Predisposition to Disease
Humans
Membrane Potential, Mitochondrial
Microscopy
Microscopy, Confocal
Microscopy, Video
Mitochondria - drug effects
Mitochondria - enzymology
Mitochondria - metabolism
Mitochondria - pathology
Mitochondrial Diseases - enzymology
Mitochondrial Diseases - genetics
Mitochondrial Diseases - metabolism
Mitochondrial Diseases - pathology
Mitochondrial Proteins - metabolism
Mitochondrial Size
Mutation
Oxidative Phosphorylation - drug effects
Reactive Oxygen Species - metabolism
Reproducibility of Results
Rotenone - pharmacology
Severity of Illness Index
Uncoupling Agents - pharmacology
title Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T09%3A27%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20NADH:ubiquinone%20oxidoreductase%20deficiency:%20radical%20changes%20in%20mitochondrial%20morphology?&rft.jtitle=American%20Journal%20of%20Physiology:%20Cell%20Physiology&rft.au=Koopman,%20Werner%20J.%20H&rft.date=2007-07-01&rft.volume=293&rft.issue=1&rft.spage=C22&rft.epage=C29&rft.pages=C22-C29&rft.issn=0363-6143&rft.eissn=1522-1563&rft.coden=AJPCDD&rft_id=info:doi/10.1152/ajpcell.00194.2006&rft_dat=%3Cproquest_highw%3E1303846101%3C/proquest_highw%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c480t-daabb55e2a2bcacbac7a9a452aceabf58fbd86d0bf66438602dca317255672dd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=230336712&rft_id=info:pmid/17428841&rfr_iscdi=true